• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.54% Nasdaq Down 0.46%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    6.34 Down 0.13(2.01%) 12:09PM EST - Nasdaq Real Time Price
    Prev Close:6.47
    Open:6.32
    Bid:6.31 x 300
    Ask:6.33 x 500
    1y Target Est:17.50
    Beta:2.08308
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:6.14 - 6.60
    52wk Range:6.14 - 28.97
    Volume:114,004
    Avg Vol (3m):781,787
    Market Cap:183.46M
    P/E (ttm):N/A
    EPS (ttm):-1.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 2.01%183.46M
    PFEDown 0.22%175.94B
    AZNDown 0.56%72.12B
    MRKDown 0.04%136.35B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.09
    Quarterly EPS Est (Dec-15) :-0.84
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-0.61

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback